UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 629

Sortiert nach

Ectopic fat and cardiovascular disease: What is the link?

Nutrition, metabolism, and cardiovascular diseases, 2010-09, Vol.20 (7), p.481-490

2010

Volltextzugriff (PDF)

Direct effect of GLP-1 infusion on endogenous glucose production in humans

Diabetologia, 2013-01, Vol.56 (1), p.156-161

2013

Volltextzugriff (PDF)

Impact of increased visceral and cardiac fat on cardiometabolic risk and disease

Diabetic medicine, 2012-05, Vol.29 (5), p.622-627

2012

Volltextzugriff (PDF)

Pioglitazone in the treatment of NASH: the role of adiponectin

Alimentary pharmacology & therapeutics, 2010-09, Vol.32 (6), p.769-775

2010

Volltextzugriff (PDF)

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

Diabetologia, 2004, Vol.47 (1), p.31-39

2004

Volltextzugriff (PDF)

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease : sites and mechanisms

Diabetologia, 2005-04, Vol.48 (4), p.634-642

2005

Volltextzugriff (PDF)

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes

Diabetologia, 2011-08, Vol.54 (8), p.2093-2102

2011

Volltextzugriff (PDF)

Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

International Journal of Obesity, 2010-03, Vol.34 (3), p.462-471

2010

Volltextzugriff (PDF)

Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity

British journal of surgery, 2019-08, Vol.106 (9), p.1178-1186

2019

Volltextzugriff (PDF)

Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD

Journal of endocrinological investigation, 2020-07, Vol.43 (7), p.1019-1026

2020

Volltextzugriff (PDF)

Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects

The journal of clinical endocrinology and metabolism, 2011-06, Vol.96 (6), p.1763-1770

2011

Volltextzugriff (PDF)

Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population

Journal of internal medicine, 2012-03, Vol.271 (3), p.294-304

2012

Volltextzugriff (PDF)

Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study

Diabetes (New York, N.Y.), 2000-08, Vol.49 (8), p.1367-1373

2000

Volltextzugriff (PDF)

Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial

Diabetes, obesity & metabolism, 2016-07, Vol.18 (7), p.711-715

2016

Volltextzugriff (PDF)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Journal of hepatology, 2016-06, Vol.64 (6), p.1388-1402

2016

Volltextzugriff (PDF)

Evaluation of Metabolic Parameters of Hepatic Dysfunction in Subjects with Hepatocellular Carcinoma and their Change after Liver Transplantation: A Metabolomic Approach

Journal of hepatology, 2016, Vol.64 (2), p.S316-S316

2016

Volltextzugriff (PDF)

The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo

Diabetic medicine, 2015-05, Vol.32 (5), p.657-664

2015

Volltextzugriff (PDF)

An extended fatty liver index to predict non-alcoholic fatty liver disease

Diabetes & metabolism, 2017-06, Vol.43 (3), p.229-239

2017

Volltextzugriff (PDF)

Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity

Diabetologia, 2013-04, Vol.56 (4), p.893-900

2013

Volltextzugriff (PDF)

AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions

Digestive and liver disease, 2017-05, Vol.49 (5), p.471-483

2017

Volltextzugriff (PDF)

A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment

Diabetes, obesity & metabolism, 2014-02, Vol.16 (2), p.170-178

2014

Volltextzugriff (PDF)

Increased carotid intima-media thickness in the physiologic range is associated with impaired postprandial glucose metabolism, insulin resistance and beta cell dysfunction

Atherosclerosis, 2013-08, Vol.229 (2), p.277-281

2013

Volltextzugriff (PDF)

Effect of Pioglitazone on the Metabolic and Hormonal Response to a Mixed Meal in Type II Diabetes

Clinical pharmacology and therapeutics, 2007-02, Vol.81 (2), p.205-212

2007

Volltextzugriff (PDF)

Exenatide Exerts Its Positive Effects on Liver by Reducing both Hepatic and Adipose Tissue Insulin Resistance

Journal of hepatology, 2016, Vol.64 (2), p.S171-S171

2016

Volltextzugriff (PDF)

Relationship between fatty liver and glucose metabolism: A cross-sectional study in 571 obese children

Nutrition, metabolism, and cardiovascular diseases, 2012-02, Vol.22 (2), p.120-126

2012

Volltextzugriff (PDF)

1 – 25 von 629

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(585)
Mit Volltextzugriff
(595)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Ectopic fat and cardiovascular disease: What is the link?

Direct effect of GLP-1 infusion on endogenous glucose production in humans

Impact of increased visceral and cardiac fat on cardiometabolic risk and disease

Pioglitazone in the treatment of NASH: the role of adiponectin

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease : sites and mechanisms

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes

Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity

Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD

Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects

Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population

Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study

Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Evaluation of Metabolic Parameters of Hepatic Dysfunction in Subjects with Hepatocellular Carcinoma and their Change after Liver Transplantation: A Metabolomic Approach

The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo

An extended fatty liver index to predict non-alcoholic fatty liver disease

Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity

AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions

A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment

Increased carotid intima-media thickness in the physiologic range is associated with impaired postprandial glucose metabolism, insulin resistance and beta cell dysfunction

Effect of Pioglitazone on the Metabolic and Hormonal Response to a Mixed Meal in Type II Diabetes

Exenatide Exerts Its Positive Effects on Liver by Reducing both Hepatic and Adipose Tissue Insulin Resistance

Relationship between fatty liver and glucose metabolism: A cross-sectional study in 571 obese children

Suchergebnisse filtern